Coronavirus disease 2019 (COVID-19) is a highly contagious disease and a serious threat to human health. COVID-19 can cause multiple organ dysfunction, such as respiratory and circulatory failure, liver and kidney injury, disseminated intravascular coagulation, and thromboembolism, and even death. The World Health Organization reports that the mortality rate of severe-type COVID-19 is over 50%. Currently, the number of severe cases worldwide has increased rapidly, but the experience in the treatment of infected patients is still limited. Given the lack of specific antiviral drugs, multi-organ function support treatment is important for patients with COVID-19. To improve the cure rate and reduce the mortality of patients with severe- and critical-type COVID-19, this paper summarizes the experience of organ function support in patients with severe- and critical-type COVID-19 in Optical Valley Branch of Tongji Hospital, Wuhan, China. This paper systematically summarizes the procedures of functional support therapies for multiple organs and systems, including respiratory, circulatory, renal, hepatic, and hematological systems, among patients with severe- and critical-type COVID-19. This paper provides a clinical reference and a new strategy for the optimal treatment of COVID-19 worldwide.
【저자키워드】 COVID-19, severe and critical type, organ function support, 【초록키워드】 Treatment, Coronavirus disease 2019, therapy, Mortality, antiviral drugs, Kidney injury, Health, Patient, Thromboembolism, death, mortality rate, disease, liver, multiple organ dysfunction, Disseminated intravascular coagulation, Support, World Health Organization, Severe case, hematological, Tongji Hospital, renal, contagious, branch, organ function, Wuhan, China, IMPROVE, lack, functional, provide, infected patient, reduce, multiple organ, patients with COVID-19, Valley, 【제목키워드】 coronavirus disease, Patient, Support,